학술논문
43271 Patient-Reported Outcomes From the Randomized Phase 2b/3 PRISM Trial Evaluating Oral Nalbuphine Extended-Release Versus Placebo in Patients With Prurigo Nodularis
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology September 2023 89(3) Supplement:AB73-AB73
Subject
Language
ISSN
0190-9622